Skip to main content
. 2022 Dec 22;5(1):fcac334. doi: 10.1093/braincomms/fcac334

Table 1.

Case characteristics

Arbitrary case # Diagnosis Age Sex PMI Notes
1 Control 47 Male 3
2 Control 60 Male 11
3 Control 68 Female 20
4 Control 76 Female 48
5 Control 89 Female 8
6 Control 90+ Male 23
7 FTLD-tau 33 Male 33 P301L
8 FTLD-tau 56 Male 26 P301L; occipital tissue unavailable
9 FTLD-tau 70 Male 12 P301L
10 FTLD-tau 71 Female 4 Poor occipital staining
11 FTLD-tau 71 Female 72
12 FTLD-tau 98 Female NA
13 CBD 64 Male 18 Frontal tissue unavailable
14 CBD 67 Female 17
15 CBD 71 Male 18
16 CBD 74 Male 18
17 CBD 80 Male 12
18 PSP 49 Male 24 Poor occipital staining
19 PSP 79 Male 4
20 PSP 79 Male 10
21 PSP 81 Female 16
22 PSP 94 Female 24

CBD, corticobasal degeneration; FTLD-tau, frontotemporal lobar degeneration-tau; NA, not available; PMI, post-mortem interval (in hours); PSP, progressive supranuclear palsy.